Géraldine Lissalde-Bonnet, GS1 Vice-President Healthcare featured in The Medicine Maker online magazine

Source: The Medicine Maker Géraldine Lissalde-Bonnet, GS1 Vice-President Healthcare, Fight The Fakes Alliance member, has been featured in The Medicine Maker online magazine with an opinion piece on the collective approach to fighting falsified medicine. In the article – Why Only a Collective Approach Can Beat Fake Medicine – Géraldine Read more…

World Alliance of Pituitary Organizations (WAPO) webinar on substandard and falsified medicines

On Thursday, 20 October at 15:00-16:00 CET, Dr. Bahijja Raimi-Abraham, Founder and Academic Lead of King’s College London Fight the Fakes academic chapter, will participate at the World Alliance of Pituitary Organizations’ (WAPO) webinar. WAPO represents the voice of 41 patient advocacies around the globe who seek to empower and improve the Quality of Read more…

Fighting the fakes: tackling substandard and falsified medicines

A recent comment written by Oksana Zirka Pyzik (UCL Fight the Fakes academic chapter founder and lead) published by nature reviews highlights how poor-quality or fraudulent medicines are causing extensive humanitarian and economic harm, particularly in Africa. Authors claim these products are a global problem that requires a coordinated cross-border response, including enhanced Read more…

Shabbir Imber Safdar, Partnership for Safe Medicines Executive Director, featured in the Medicine Maker

Image by the Medicine Maker Shabbir Imber Safdar, Partnership for Safe Medicines Executive Director and Fight the Fakes board member, was recently featured in the Medicine Maker online magazine. In his article “Drug Supply Chain Security Act” Shabbir discussed how the US drug supply chain is not immune to falsified medicines Read more…

The full Replenishment of the Global Fund is vital to keeping patients safe from falsified and substandard medicines

Fight the Fakes Alliance calls upon national governments to ensure that the 7th replenishment of the Global Fund to fight AIDS, Tuberculosis and Malaria, planned for September 2022, is met in full to help avoid the entry of substandard and falsified medicines in low-and middle income countries. The replenishment of Read more…